Valuation Center Laboratories, Inc.

Stocks

End-of-day quote Taipei Exchange 2026-10-28			5-day change	1st Jan Change
29.50 ^TWD	-1.01%		-1.34%	-25.55%

08-11	Center Laboratories, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
07-20	GenEditBio Limited announced that it has received TWD 550 million in funding from Center Laboratories, Inc.	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2020	2021	2022	2023	2024	2025
Market Cap ¹	31,736	30,555	28,132	30,630	31,591	31,056
Change	-	-3.72%	-7.93%	8.88%	3.14%	-1.69%
Enterprise Value (EV) ¹	34,577	31,068	29,252	32,827	36,070	35,097
Change	-	-10.15%	-5.84%	12.22%	9.88%	-2.7%
P/E	8.42x	17.3x	278x	-29.5x	-28.2x	3.64x
PBR	1.76x	1.61x	1.46x	1.54x	1.75x	1.17x
PEG	-	-0.3x	-2.9x	0x	-7.71x	-0x
Capitalization / Revenue	44.3x	61.1x	36.6x	22x	19.5x	20.5x
EV / Revenue	48.2x	62.1x	38.1x	23.5x	22.3x	23.1x
EV / EBITDA	-82x	-141x	92.5x	152x	94.1x	-175x
EV / EBIT	-73.3x	-122x	103x	418x	154x	-97.1x
EV / FCF	6,826x	-5.65x	4.54x	-13.9x	547x	132x
FCF Yield	0.01%	-17.7%	22%	-7.22%	0.18%	0.76%
Dividend per Share ²	0.9789	1.751	0.8179	1.36	0.6799	1.664
Rate of return	2.16%	4.02%	2.1%	3.39%	1.71%	4.2%
EPS ²	5.383	2.519	0.1402	-1.36	-1.41	10.9
Distribution rate	18.2%	69.5%	583%	-100%	-48.2%	15.3%
Net sales ¹	717	500.1	767.7	1,394	1,618	1,516
EBITDA ¹	-421.5	-220.8	316.1	216	383.2	-200.9
EBIT ¹	-471.8	-254.2	284.1	78.56	234.1	-361.6
Net income ¹	3,786	1,816	102.2	-995.4	-1,104	9,323
Net Debt ¹	2,841	512.5	1,120	2,197	4,480	4,041
Reference price ²	45.35	43.54	39.01	40.16	39.75	39.62
Nbr of stocks (in thousands)	699,786	701,772	721,156	762,726	794,720	783,789
Announcement Date	3/31/21	3/30/22	3/28/23	3/19/24	3/14/25	3/9/26

¹TWD in Million²TWD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
CENTER LABORATORIES, INC.	-	-	-	-	727M
ELI LILLY AND COMPANY	37.66x	13.18x	27.98x	0.53%	1,143B
JOHNSON & JOHNSON	39.33x	6.61x	18.6x	1.99%	647B
ABBVIE INC.	37.45x	8.4x	17.37x	2.4%	506B
ROCHE HOLDING AG	21.46x	5.22x	12.98x	2.51%	384B
MERCK & CO., INC.	103.38x	5.8x	24.86x	2.4%	350B
NOVARTIS AG	21.99x	5.69x	13.69x	2.94%	293B
ASTRAZENECA PLC	22.31x	4.51x	12.87x	1.96%	265B
AMGEN INC.	28.42x	7.28x	13.03x	2.25%	242B
GILEAD SCIENCES, INC.	-45.78x	7.1x	27.53x	2.07%	197B
Average	29.58x	7.09x	18.77x	2.12%	402.83B
Weighted average by Cap.	35.27x	8.35x	20.48x	1.8%